Atlas Trials

Navitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid Tumors

Clinical trial NCT03366103 · TERMINATED

Trial details

NCT number
NCT03366103
Sponsor
National Cancer Institute (NCI)
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metastatic Malignant Solid NeoplasmRecurrent Lung Small Cell CarcinomaRecurrent Malignant Solid NeoplasmRefractory Malignant Solid NeoplasmStage III Lung Small Cell Carcinoma, by American Joint Committee on Cancer (AJCC) v7Stage IIIA Lung Small Cell Carcinoma AJCC v7Stage IIIB Lung Small Cell Carcinoma AJCC v7Stage IV Lung Small Cell Carcinoma AJCC v7Unresectable Solid Neoplasm
Start date
2018-03-20
Primary completion
2021-07-28
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.